Activation of Chymotrypsinogen by Preparations of Thrombokinase Derived from Bovine Plasma

Summary

Activation of chymotrypsinogen by thrombokinase was observed by the use of benzoyl tyrosine ethylester, which was hydrolyzed by chymotrypsin but not by thrombokinase. Optimal pH was 7.5 to 7.7; and 0.0035 M calcium chloride was beneficial. The ratio of chymotrypsinogen to thrombokinase could reach 1,000, without evidence that the zymogen was saturating the activator. But it was convenient to use a ratio near 20, with 2 mg chymotrypsinogen/ml. The early rate of activation was proportional to the concentration of thrombokinase; and this was made the basis for an assay of activator.

The thrombokinase was a highly purified derivative of bovine plasma; but it was a weak chymotrypsinogen activator compared to trypsin. Nevertheless, activation could proceed in the presence of pancreatic trypsin inhibitor, in which case added trypsinogen caused no acceleration. Apparently, the activating effect was exerted directly on chymotrypsinogen. The ratio of activator to thrombin increased 2,000 fold during purification. Hence, activation was not due to the remaining trace of thrombin; although it could be due to some other impurity. However, it is possible that a single enzyme, namely thrombokinase, is able to split toluenesulfonylarginine methylester and also to activate prothrombin and chymotrypsinogen, respectively.

• References

• 1 Milstone J. H, Milstone V. K. Proc. Soc. exp. Biol. (N. Y.) 117: 290 1964;
• 2 Milstone J. H, Oulianoff N, Milstone V. K. Proc. Soc. exp. Biol. (N. Y.) 119: 804 1965;
• 3 Milstone J. H. J. gen. Physiol 45 (Suppl. 04) pt. 2 103 1962;
• 4 Milstone J. H. J. gen. Physiol 42: 665 1959;
• 5 Milstone J. H, Oulianoff N, Milstone V. K. J. gen. Physiol 47: 315 1963;
• 6 Northrop J. H, Kunitz M, Herriott R. M. Crystalline Enzymes. Columbia University Press; New York: 1948. 2nd ed.. 96.
• 7 Balls A. K. Proc. nat. Acad. Sci. (Wash.) 53: 392 1965;
• 8 Kunitz M, Northrop J. H. J. gen. Physiol 19: 991 1936;
• 9 Sherry S, Troll W. J. biol. Chem 208: 95 1954;
• 10 Hummel B. G. W. Canad. J. Biochem 37: 1393 1959;
• 11 Lowry O. H, Rosebrough N. J, Farr A. L, Randall R. J. J. biol. Chem 193: 265 1951;
• 12 Neurath H. Advanc. Protein Chem 12: 319 1957;
• 13 Erlanger B. F, Cooper A. G, Bendich A. J. Biochemistry 3: 1880 1964;
• 14 Engel A, Alexander B. Fed. Proc 23: 299 1964;
• 15 Kunitz M, Northrop J. H. Science 78: 558 1933;
• 16 Hess B. Enzymes in Blood Plasma. Translated by K. S. Henley Academic Press; New York and London: 1963
• 17 Wu F. G, Laskowski M. J. biol. Chem 213: 609 1955;
• 18 Milstone J. H. Proc. Soc. exp. Biol. (N. Y.) 103: 361 1960;
• 19 Macfarlane R. G. Nature (Lond.) 202: 498 1964;
• 20 Davie E. W. O, Ratnoff D. Science 145: 1310 1964;
• 21 Breckenridge R. T, Ratnoff O. D. J. clin. Invest 44: 302 1965;
• 22 Milstone J. H. J. gen. Physiol 38: 757 1955;
• 23 Milstone J. H. Fed. Proc 23: 742 1964;
• 24 Seegers W. H, Cole E. R, Aoki N. Canad. J. Biochem 41: 2441 1963;
• 25 Papahadjopoulos D, Hanahan D. J. Biochim. biophys. Acta (Amst.) 90: 436 1964;
• 26 Esnouf M. P, Jobin F. Thrombos. Diathes. haemorrh. (Stuttg.) suppl. 17: 103 1965;
• 27 Bergsagel D. E, Nockolds E. R. Brit. J. Hemat 11: 395 1965;
• 28 Breckenridge R. T, Ratnoff O. D. Blood 27: 527 1966;
• 29 Marciniak E, Seegers W. H. New Istanbul Contr. clin. Sci 8: 117 1965;
• 30 Seegers W. H, Heene D. L, Marciniak E. Thrombos. Diathes. haemorrh. (Stuttg.) 15: 1 1966;
• 31 Esnouf M. P, Williams W. J. Thromb. Diathes. haemorrh. (Stuttg.) 7 (Suppl. 01) 213 1961; -62
• 32 Sherry S, Alkjaersig N, Fletcher A. P. Amer. J. Physiol 209: 577 1965;
• 33 Neurath H. Fed. Proc 23: 1 1964;